Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials.
Following China's pharma scandal, investors are buying a firm's claim to be developing a vaccine-tracking blockchain, but one regulator isn't happy.